Shilpa Medicare is engaged in the business of high quality Active Pharmaceuticals Ingredients (APIs), Intermediates, Formulations, New Drug delivery system, Peptides, Biotech
Categories
API
Natco Pharma Ltd Q3FY24; 244% rise in Profits
NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products
Laurus Labs Ltd Q3FY24; 89% fall in Profits
Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active Pharmaceutical Ingredients
Divi’s Laboratories Ltd Q3 FY24 Earnings Conference Call Insights
Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q3 FY24 Earnings Concall Growth and Performance Witnessed a steady 3Q driven by expanding market
Unichem Laboratories Ltd Q3FY24; 44% rise in Revenue
Unichem Laboratories Ltd is involved in pharmaceuticals in Generics, APIs and Contract Manufacturing (CMO) areas. Financial Results: Unichem Laboratories Ltd reported Revenues
Themis Medicare Ltd Q2FY24; 39% fall in Profits
Themis Medicare is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity. Financial Results:
RPG Life Sciences Ltd Q2FY24; 30% rise in Profits
RPG Life Sciences Ltd is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs) in
Supriya Lifescience Ltd Q2FY24; 41% rise in Profits
Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs
Sequent Scientific Ltd Q2FY24; 2% rise in Revenue
Sequent Scientific is India's leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides a wide-ranging
Divi’s Laboratories Ltd Q2 FY24 Earnings Conference Call Insights
Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q2 FY24 Earnings Concall Business Overview Anticipating growth opportunities in contrast media, sartans, soon-to-expire patented
Sun Pharmaceuticals Industries Ltd Q2FY24; 6% rise in Profits
Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations
Unichem Laboratories Ltd Q2FY24; 26% rise in Revenue
Unichem Laboratories Ltd is involved in pharmaceuticals in Generics, APIs and Contract Manufacturing (CMO) areas. Financial Results: Unichem Laboratories Ltd reported Revenues
A Primer on India’s Oldest Pharma Company Ft Alembic Pharmaceuticals
“The company grew in all the business segments with India outperforming the market with 9% growth, Ex US generics grew 46%, API
Remedium Lifecare Ltd Q1FY24; 19% fall in Profits
Incorporated in 1988, Remedium Lifecare Ltd is in the business of trading in Advanced Pharmaceutical Intermediates and other pharma products. Financial Results:
Nectar Lifescience Ltd Q1FY24; 53% fall in Profits
Nectar Lifesciences Ltd is primarily engaged in the development, manufacture and marketing of various active pharmaceutical ingredients (APIs) and finished dosage forms.
Themis Medicare Ltd Q1FY24; 6% rise in Profits
Themis Medicare is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity. Financial Results:
Mangalam Drugs and Organics Ltd Q1FY24; 20% fall in Revenue
Mangalam Drugs & Organics Limited is engaged in manufacturing pharma APIs, Intermediates and Specialty Chemicals. Financial Results: Mangalam Drugs and Organics Ltd
Shilpa Medicare Ltd Q1FY24; 50% fall in Profits
Shilpa Medicare is engaged in the business of high quality Active Pharmaceuticals Ingredients (APIs), Intermediates, Formulations, New Drug delivery system, Peptides, Biotech
Granules India Ltd Q1FY24; 62% fall in Profits
Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates
Suven Pharmaceuticals Ltd Q1FY24; 12% rise in Profits
Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma Industry. Financial
SMS Pharmaceuticals Ltd Q1FY24; 110% rise in Revenue
SMS Pharmaceuticals Ltd is a diversified and integrated pharmaceutical company with interests in Active Pharmaceutical Ingredients (API) and Intermediates. Financial Results: SMS